Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Glypican 3 16 found (22 total)

alternate case: glypican 3

Single-domain antibody (3,499 words) [view diff] no match in snippet view article find links to article

Chen W, Man YG, Figg WD, et al. (March 2013). "Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma"
Heparan sulfate (3,653 words) [view diff] no match in snippet view article find links to article
receptor binding site and as a result, protein-HS complexes are inactive. Glypican-3 (GPC3) interacts with both Wnt and Frizzled to form a complex and triggers
Hippo signaling pathway (3,191 words) [view diff] no match in snippet view article find links to article
not been positively identified. The GPI-anchored cell surface protein glypican-3 (GPC3) is known to interact with Fat1 in human liver cancer. GPC3 is also
A431 cells (507 words) [view diff] no match in snippet view article find links to article
2012). "High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry
Glypican (2,310 words) [view diff] no match in snippet view article find links to article
glypican-1 is overexpressed in breast and brain cancers (gliomas), while glypican-3 is overexpressed in liver cancers. Glypican-2 is overexpressed in neuroblastoma
WNT7B (778 words) [view diff] no match in snippet view article find links to article
Filmus J (December 2005). "Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth". The Journal of
Keratin 20 (1,176 words) [view diff] no match in snippet view article find links to article
PMID 18587323. He H, Fang W, Liu X, et al. (2009). "Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases". Appl
Simpson–Golabi–Behmel syndrome (1,316 words) [view diff] no match in snippet view article find links to article
SGBS have been identified, one cause of SGBS type I is a mutation of the glypican-3 gene (GPC3) on the X chromosome locus q26.1. This particular gene is widely
Glypican 4 (575 words) [view diff] exact match in snippet view article find links to article
Chen E, Ireland M, Lindsay S, Pilia G, Crisponi L (December 1998). "Glypican 3 and glypican 4 are juxtaposed in Xq26.1". Gene. 225 (1–2): 9–16. doi:10
WNT3A (1,637 words) [view diff] no match in snippet view article find links to article
Filmus J (December 2005). "Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth". The Journal of
MIR1271 (357 words) [view diff] no match in snippet view article find links to article
(2013). "A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma". Hepatology
Tak Wah Mak (1,591 words) [view diff] no match in snippet view article find links to article
Jumaa H, Reth M, Weiss A, Lowell CA, Müschen M. 10.1038/nature14231 1999 Glypican-3–Deficient Mice Exhibit Developmental Overgrowth and Some of the Abnormalities
Affimer (2,362 words) [view diff] no match in snippet view article find links to article
"Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3". Scientific Reports. 7 (1): 9608. Bibcode:2017NatSR...7.9608X. doi:10
SULF1 (6,562 words) [view diff] no match in snippet view article find links to article
knockdown eliminated migration and proliferation. Sulf2 also upregulated glypican-3, which is commonly overexpressed in HCC, by increasing ERK, AKT activation
Mesothelin (2,831 words) [view diff] no match in snippet view article find links to article
(October 2011). "Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin". BioDrugs. 25 (5): 275–84. doi:10.2165/11595360-000000000-00000
Chimeric antigen receptor T cell (6,504 words) [view diff] exact match in snippet view article find links to article
"Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice". Gastroenterology